Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Torticollis, Difficulty swallowing (dysphagia), Lower limb hyperreflexia, and Limb dystonia and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Difficulty swallowing (dysphagia), Lower limb hyperreflexia, Limb dystonia |
VPS11 function has not been fully characterized.
Dystonia 32 is associated with mutations in the VPS11 gene on chromosome 11.
Genetic testing for VPS11 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for dystonia 32 has been reported in the published literature.
Phenotype severity distribution: 8 always present features.
No clinical trials have been registered for dystonia 32.
121 publications have been identified in PubMed for dystonia 32. Research spans Clinical Trial Publication (22%), Case Report / Case Series (17%), and Review / Meta-Analysis (16%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 27 | 22% |
Data assembled from 5 of 12 sources · Last updated Sep 17, 2026, 8:34 PM UTC
Online Mendelian Inheritance in Man
2 |
Lower limb hyperreflexia, Limb dystonia |
Digestive system | 1 | Difficulty swallowing (dysphagia) |
Muscles | 1 | Brain atrophy |
20 |
17% |
Research summaries | 19 | 16% |
Disease patterns and progression | 18 | 15% |
Laboratory research | 15 | 12% |
Testing and diagnosis research | 14 | 12% |
New treatment approaches | 7 | 6% |
Other research | 1 | 1% |
He X (2026). [PMID: 40029543](https://pubmed.ncbi.nlm.nih.gov/40029543/). *Anatomical science international*. [Basic Science / Preclinical]
Best C (2026). [PMID: 42260058](https://pubmed.ncbi.nlm.nih.gov/42260058/). *Sci Rep*. [Other]
Cheng X (2026). [PMID: 41731592](https://pubmed.ncbi.nlm.nih.gov/41731592/). *Molecular cytogenetics*. [Gene Therapy / Novel Therapeutics]
Pañares KA (2026). [PMID: 42228034](https://pubmed.ncbi.nlm.nih.gov/42228034/). *J Neural Transm (Vienna)*. [Epidemiology / Natural History]
Rai SM (2026). [PMID: 42497469](https://pubmed.ncbi.nlm.nih.gov/42497469/). *J Neuroimmunol*. [Epidemiology / Natural History]
Mahale RR (2026). [PMID: 42371055](https://pubmed.ncbi.nlm.nih.gov/42371055/). *J Neural Transm (Vienna)*. [Case Report / Case Series]
Courtin E (2026). [PMID: 41482469](https://pubmed.ncbi.nlm.nih.gov/41482469/). *Journal of neurology, neurosurgery, and psychiatry*. [Gene Therapy / Novel Therapeutics]
Hurt CC (2026). [PMID: 41605715](https://pubmed.ncbi.nlm.nih.gov/41605715/). *Journal of voice : official journal of the Voice Foundation*. [Clinical Trial Publication]
Sherman BC (2026). [PMID: 42454897](https://pubmed.ncbi.nlm.nih.gov/42454897/). *Oper Neurosurg*. [Case Report / Case Series]
Gao J (2026). [PMID: 41526335](https://pubmed.ncbi.nlm.nih.gov/41526335/). *Cell death & disease*. [Gene Therapy / Novel Therapeutics]